SCHEMBL6344654

SCHEMBL6344654

Cc1nn(-c2ccccn2)c2nc(-c3ccccc3)cc(O)c12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.66
KDM4E B2RXH2 9/20 0.66
HPGD P15428 6/20 0.66
MAPT P10636 5/20 0.66
GAA P10253 2/20 0.66
NPSR1 Q6W5P4 2/20 0.66
HTT P42858 1/20 0.66
TSHR P16473 3/20 0.58
USP2 O75604 1/20 0.58
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
SPR P35270 4/20 0.45
HSD17B10 Q99714 3/20 0.45
POLB P06746 1/20 0.45
ALOX15 P16050 1/20 0.44
TP53 P04637 1/20 0.44
FFAR4 Q5NUL3 3/20 0.41
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353217 0.85 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL6344875 0.81 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL6341599 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL11644725 0.78 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL6343586 0.78 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL6342512 0.77 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL6341838 0.76 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL6342998 0.76 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL11642562 0.74 KDM4E (0.49) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL6343049 0.73 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 ALDH1A1 1061/4885KDM4E 1741/4885HPGD 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.